ArticleScientific reports2021

Next generation proteomics with drug sensitivity screening identifies sub-clones informing therapeutic and drug development strategies for multiple myeloma patients.

Ciara Tierney et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.